Related Experiment Videos
Substance P regulates PTH secretion through the neurokinin-1 receptor
R J Galvin1, L E Babbey, P A Hipskind
1Endocrine Division, Neurosciences Division, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. Galvin_Rachelle_J_S@Lilly.com
Biochemical and Biophysical Research Communications
|March 29, 2000
Summary
Substance P (SP) regulates parathyroid hormone (PTH) secretion via NK-1 receptors, particularly at low calcium levels. This discovery reveals a new neuroendocrine pathway influencing PTH release.
Area of Science:
- Neuroendocrinology
- Cellular Physiology
Background:
- Parathyroid hormone (PTH) secretion is primarily regulated by serum ionized calcium (Ca2+).
- Nerve fibers containing neuropeptides have been identified in the parathyroid gland, suggesting potential neural regulation of PTH secretion.
Purpose of the Study:
- To investigate whether the neuropeptide substance P (SP) plays a role in regulating PTH secretion.
- To elucidate the specific receptor mechanism involved in SP-mediated effects on PTH release.
Main Methods:
- Utilized dispersed porcine parathyroid cells for in vitro studies.
- Assessed the effects of SP, NK-1, NK-2, and NK-3 receptor agonists on PTH secretion under varying CaCl2 concentrations.
- Employed RT-PCR to detect NK-1 receptor mRNA expression in parathyroid cells.
- Investigated the role of a selective NK-1 receptor antagonist (LY306740) in reversing SP's effects.
Main Results:
- SP reversibly inhibited CaCl2-induced PTH secretion at low calcium concentrations (0.5 mM CaCl2) with an IC50 of 0.29 nM.
- A selective NK-1 receptor agonist mimicked SP's inhibitory effect on PTH secretion at 0.5 mM CaCl2 (IC50 = 0.21 nM).
- NK-2 and NK-3 receptor agonists showed significantly less activity compared to SP and the NK-1 agonist.
- The NK-1 antagonist LY306740 specifically reversed the effects of SP on PTH secretion.
- NK-1 receptor mRNA was detected in porcine parathyroid cells.
Conclusions:
- Substance P (SP) acts as a regulator of PTH secretion.
- This regulation occurs through the activation of NK-1 receptors located on parathyroid cells.
- A novel neuroendocrine pathway involving SP and NK-1 receptors in modulating PTH secretion has been identified.